Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter Noninferiority Trial Comparing Chemoradiotherapy Versus Esophagectomy After Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma (ASSURE)

NCT03306901 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03306901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03306901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter Noninferiority Trial Comparing Chemoradiotherapy Versus Esophagectomy After Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma (ASSURE)
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 20, 2017
Completion date
December 31, 2033
Enrollment
240 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer